Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of bone remodeling, the processes of bone formation and resorption that combine to maintain skeletal integrity. [GOC:ai]
Bone remodeling is a continuous process of bone formation and resorption that maintains bone mass, shape, and strength. It involves a complex interplay of cells, signaling molecules, and mechanical stimuli.
**1. Bone Resorption:**
- Osteoclasts are multinucleated cells responsible for bone resorption.
- They attach to the bone surface and release enzymes (e.g., cathepsin K) and acids that degrade bone matrix.
- This process releases calcium, phosphate, and other minerals into the bloodstream.
**2. Bone Formation:**
- Osteoblasts are cells responsible for bone formation.
- They synthesize and secrete bone matrix proteins (e.g., collagen) and mineralize it with calcium and phosphate.
- The process involves several stages:
- **Proliferation:** Osteoblasts multiply.
- **Differentiation:** Osteoblast precursors mature into functional osteoblasts.
- **Matrix synthesis and mineralization:** Osteoblasts produce bone matrix and mineralize it.
- **Apoptosis:** After completing their function, osteoblasts undergo programmed cell death.
**3. Regulation of Bone Remodeling:**
- **Hormonal Control:**
- **Parathyroid hormone (PTH):** Stimulates osteoclast activity and increases bone resorption.
- **Calcitonin:** Inhibits osteoclast activity and decreases bone resorption.
- **Vitamin D:** Promotes calcium absorption from the gut, which is necessary for bone formation.
- **Estrogen:** Inhibits bone resorption and promotes bone formation.
- **Growth hormone:** Stimulates bone growth and remodeling.
- **Mechanical Stimuli:**
- **Mechanical stress:** Increases bone formation and remodeling.
- **Microdamage:** Triggers bone repair and remodeling.
- **Cytokines and Growth Factors:**
- **RANKL (receptor activator of nuclear factor κB ligand):** A cytokine that stimulates osteoclast differentiation and activity.
- **OPG (osteoprotegerin):** A protein that inhibits osteoclast activity by binding to RANKL.
- **BMPs (bone morphogenetic proteins):** Growth factors that promote osteoblast differentiation and bone formation.
- **TGF-β (transforming growth factor beta):** A growth factor that regulates both bone formation and resorption.
**4. Coupling of Bone Resorption and Formation:**
- Bone resorption and formation are tightly coupled to ensure proper bone maintenance.
- Osteoclast activity creates resorption pits, which serve as sites for osteoblast activity.
- Signaling molecules released during resorption stimulate osteoblast differentiation and activity.
**5. Dysregulation of Bone Remodeling:**
- Imbalances in bone remodeling can lead to various bone disorders, including:
- **Osteoporosis:** Characterized by low bone mass and increased bone fragility.
- **Osteogenesis imperfecta:** A genetic disorder that affects bone formation.
- **Paget's disease of bone:** A chronic bone disorder that leads to excessive bone turnover.
- **Bone tumors:** Abnormal bone growth that can disrupt bone remodeling.'
"
Protein | Definition | Taxonomy |
---|---|---|
Gap junction alpha-1 protein | A gap junction alpha-1 protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17302] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
kanamycin a | kanamycin : Kanamycin is a naturally occurring antibiotic complex from Streptomyces kanamyceticus that consists of several components: kanamycin A, the major component (also usually designated as kanamycin), and kanamycins B, C, D and X the minor components. Kanamycin: Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. | kanamycins | bacterial metabolite |